Eden Research (LON:EDEN) Shares Up 16.7% – Should You Buy?

Eden Research plc (LON:EDEN) shares shot up 16.7% on Tuesday . The company traded as high as GBX 4.98 and last traded at GBX 4.90. 1,670,452 shares changed hands during mid-day trading, an increase of 50% from the average session volume of 1,110,116 shares. The stock had previously closed at GBX 4.20.

Eden Research Trading Up 16.7%

The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The business has a 50 day moving average price of GBX 2.64 and a 200-day moving average price of GBX 2.87. The firm has a market capitalization of £26.13 million, a PE ratio of -11.06 and a beta of 0.92.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.